Opinion|Videos|July 9, 2024
The Impact of Payer Coverage and Reimbursement on Biosimilars
Dr. Cannon leads a conversation navigating the impact of payer coverage on the uptake of biosimilars.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How are payer coverage and reimbursement policies impacting the uptake of biosimilars? What have you observed in your practice?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC
2
Novel CLL Therapies Prompt New Treatment Considerations
3
Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD
4
Balancing Innovation With Administrative Burdens in Cancer Care
5
